Hypoglycemia is a term that describes dangerously low blood sugar, which manifests with shaking, sweating, dizziness, hunger, confusion, and loss of consciousness
Across FDA-approved GLP-1 labels, nausea affects roughly 1244% of trial participants, and gastrointestinal symptoms cluster in the two to four weeks after each dose change which is exactly why side effects logged beside dose timing tell you more than side effects logged alone
The rest of its advice, hydration, sufficient sleep and protein-rich meals, is framed as supporting habits around it
Semaglutide is administered via injection
That systemic physiology should be closer to the forefront of our clinical reasoning
People interested in healthy ageing and cell repair